Canada Advanced Therapy Medicinal Products (ATMPs) Market Analysis

Canada Advanced Therapy Medicinal Products (ATMPs) Market Analysis


$ 3999

Canada's Advanced Therapy Medicinal Products (ATMPs) market is likely to grow at a CAGR of 13% from a market size of $0.81 Bn in 2022 to $2.15 Bn in 2030. The major growth drivers driving the market are the increasing prevalence of chronic diseases and the growing investment in the industry. This report is segmented by product type, disease type, and by distribution channel. Some key players in this market include Novartis, Celgene Corporation, Gilead Lifesciences, Bluebird Bio, and others.

ID: IN10CAPH029 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Dhruv Joshi

Buy Now

Canada Advanced Therapy Medicinal Products (ATMPs) Market Executive Summary

Canada's Advanced Therapy Medicinal Products (ATMPs) Market size is at around $0.81 Bn in 2022 and is projected to reach $2.15 Bn in 2030, exhibiting a CAGR of 13% during the forecast period 2022-2030. One of the largest nations in the globe and the largest in the western hemisphere is Canada. With firms ranging from little owner-managed businesses to multinational corporations, it boasts a thriving free-market economy. In the past, the export of agricultural staples, primarily grain, as well as the production and sale of natural resource exports, such as minerals, oil and gas, and forest products, were the foundations of Canada's economy.

The public sector finances healthcare services and the private sector provides these services, in Canada's hybrid public-private healthcare system. There is currently no national procurement model that is uniform. Each province like British Columbia, Ontario, Quebec, and others has its own set of regulations, which can vary significantly between regions or service providers. Provincial governments are implementing or looking at healthcare procurement reforms, including centralized approaches. The research, development, production, and distribution of medications are all covered by the pharmaceutical industry. Global pharmaceutical sales hit $1.42 trillion in 2021 as a result of the market's explosive growth during the previous 20 years. The manufacturing sector has seen a substantial transformation due to the advent of new technologies as well as more cost-effective and efficient manufacturing methods. Moreover, increasing investment flow in this industry has favorably influenced market growth.

Advanced Treatment Medicinal Products (ATMPs) have the ability to treat the underlying cause of disease as opposed to just treating the symptoms. ATMPs help give revolutionary advantages that are not provided by traditional therapy. These elements are anticipated to drive the market during the forecast period.

canada advanced therapy medical products market analysis

Market Dynamics

Market Growth Drivers

In Canada, chronic diseases like cancer, diabetes, and heart disease are major causes of concern. In the upcoming years, demand for ATMPs may increase as a result of their potential to treat various disorders with focused and individualized therapies. The Canadian government has taken initiatives to promote the growth of the ATMP sector. This includes legislative frameworks that permit accelerated approval of these goods as well as funding schemes for ATMP research and development. Technology advancements like CRISPR gene editing and 3D printing are spurring innovation in the ATMP sector. These developments are making it possible to create more sophisticated and successful treatments, which could be very advantageous for patients. Venture capital firms have made large investments in the ATMP sector. This investment is promoting the creation of new goods and technology and expands the funding sources for the development of ATMPs. In Canada, several ATMP products are now being developed, including tissue engineering goods for wound healing, cell therapies for cancer, and gene therapies for uncommon disorders. The demand for ATMPs may increase as a result of these products' ability to solve important unmet medical needs in the years to come.

Market Restraints

ATMP development can be expensive, especially for small businesses and startups. For businesses wishing to enter the ATMP sector, these high prices can be a substantial barrier, which may reduce industry competitiveness and innovation. ATMP manufacture calls for specific equipment and facilities, which can be costly to create and maintain. Due to production constraints caused by this restricted manufacturing capacity, the marketability of ATMPs may be constrained. ATMPs can be expensive to construct and manage, which makes reimbursement difficult. Also, the reimbursement procedure for these items could not be well understood, which might prevent widespread market acceptance.

Competitive Landscape

Key Players

  • Novartis
  • Celgene Corporation
  • Gilead Lifesciences
  • Bluebird Bio
  • Spark Therapeutics
  • Kolon TissueGene

Healthcare Policies and Regulatory Landscape

Gene treatments, cell therapies, and tissue-engineered products all fall under the category of advanced therapy medicinal products (ATMPs). Health Canada, the nation's regulatory body for pharmaceuticals and medical devices, oversees ATMP regulation in Canada. To guarantee the security, efficiency, and calibre of ATMPs, Health Canada has devised a regulatory framework. This framework features an accelerated assessment and approval process for ATMPs, allowing for streamlined regulatory oversight of these goods. ATMPs need to adhere to the same regulatory standards as other medications and biologics in order to be used in Canada. This entails adhering to Good Manufacturing Procedures (GMP) for the development and testing of the product, as well as preclinical and clinical testing to determine its safety and effectiveness. Companies creating ATMPs can also get advice from Health Canada, including how to create gene treatments, cell therapies, and tissue-engineered goods. This advice provides suggestions for clinical trial layout as well as instructions for the production and quality assurance of these items. There are only a few ATMPs that have been authorized for use in Canada as of yet. Nonetheless, a variety of ATMP products are being developed in Canada, including tissue-engineered products for wound healing, cell therapies for cancer, and gene therapies for uncommon disorders.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Advanced Therapy Medicinal Products (ATMPs) Market Segmentation

By Product Type (Revenue, USD Billion):

  • Cell Therapy
  • Gene Therapy
  • CAR-T Therapy
  • Tissue Engineered Product

By Disease Type (Revenue, USD Billion):

  • Alzheimer's
  • Cystic Fibrosis
  • Muscular Dystrophies
  • Hemophilia

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacy
  • Drug Store
  • Retail Store
  • Online Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 29 March 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up